G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -99.4% | 266 | -98.8% | 0.00% | – |
| Q1 2022 | $171,000 | -25.7% | 22,561 | +0.2% | 0.00% | – |
| Q4 2021 | $230,000 | -43.1% | 22,523 | -25.2% | 0.00% | – |
| Q3 2021 | $404,000 | -47.2% | 30,116 | -13.7% | 0.00% | -100.0% |
| Q2 2021 | $765,000 | -2.4% | 34,884 | +7.0% | 0.00% | 0.0% |
| Q1 2021 | $784,000 | +33.8% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $586,000 | +55.4% | 32,600 | 0.0% | 0.00% | – |
| Q3 2020 | $377,000 | -52.3% | 32,600 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $791,000 | +120.3% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $359,000 | -58.4% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $862,000 | +1.2% | 32,600 | -12.8% | 0.00% | 0.0% |
| Q3 2019 | $852,000 | -19.9% | 37,400 | +7.8% | 0.00% | 0.0% |
| Q2 2019 | $1,064,000 | +212.9% | 34,700 | +69.3% | 0.00% | – |
| Q1 2019 | $340,000 | -13.5% | 20,500 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $393,000 | -69.3% | 20,500 | -16.3% | 0.00% | -50.0% |
| Q3 2018 | $1,281,000 | +29.8% | 24,500 | +7.9% | 0.00% | +100.0% |
| Q2 2018 | $987,000 | +144.3% | 22,700 | +108.3% | 0.00% | 0.0% |
| Q1 2018 | $404,000 | +186.5% | 10,900 | +53.5% | 0.00% | – |
| Q4 2017 | $141,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |